Meningococcal disease is a highly contagious, life-threatening illness. Even with treatment, the condition can cause long-term disability such as loss of limbs, deafness, and brain damage.

There are five strains of meningococcal bacteria (A, B, C, W & Y) that most commonly cause meningococcal disease. Currently, there is no single vaccine available that includes protection against all five strains at once.

Here at AusTrials, we are testing an experimental combined vaccine which may provide protection against the five strains of meningococcal bacteria that can cause meningococcal disease.

You may be eligible for this study if:

• You are healthy and between 18 and 50 years old
• You have never received a vaccine against the A, C, W, and Y strains of meningococcal bacteria, or you received this vaccine at least four years ago
• You have never received a vaccine against the B strain of meningococcal bacteria

The study is being conducted at the following locations:

• Taringa, QLD
• Wellers Hill, QLD

The study involves four clinic visits and three phone calls over the span of eight or twelve months. Eligible participants will receive the vaccinations free of charge and will be compensated for their time and travel.

Please contact AusTrials on 07 3278 5255 for further information or follow the link below and we will get back to you.

Use the links at the bottom of the page to share this study on social media or by email with friends or family who may be interested.

Seasonal influenza is a respiratory illness that affects the lungs and breathing passages. It spreads easily from person to person, and in severe cases, it can potentially lead to hospitalisation and death.

Here at AusTrials, we are conducting a study to compare an investigational messenger RNA vaccine with an alternative vaccine that is currently being used to protect against seasonal influenza.

The study involves up to seven visits to our dedicated research facility and six follow-up phone calls.

Eligible participants will be compensated for their travel-related costs.

You may be eligible for this study if you are at least 18 years of age and are generally healthy.

The study is being conducted at the following location:

• Wellers Hill, QLD

Please contact AusTrials on 07 3278 5255 for further information or follow the link below.

Use the links at the bottom of the page to share this study on social media or by email with friends or family who may be interested.

Hay fever (Allergic Rhinitis) is a common condition which can have a major impact on quality of life, emotional well-being, daily activities, productivity, and sleep.

Here at AusTrials, we are testing an investigational drug-free nasal spray which may prevent allergens from entering the nose.

The study involves three visits to our dedicated research facility and two follow-up phone calls. Eligible participants will be compensated for their time and travel.

You may be eligible for this study if you:

• Are between 18 and 75 years of age
• Have a history of seasonal hay fever and are currently experiencing symptoms

The study is being conducted at the following locations:

• Taringa, QLD
• Wellers Hill, QLD

Please contact AusTrials on 07 3278 5255 for further information or follow the link below

Use the links at the bottom of the page to share this study on social media or by email with friends or family who may be interested.

Despite the success of the vaccine roll-out and the easing of restrictions, Covid-19 remains a global threat. Volunteering in clinical research is a great way to contribute to scientific knowledge and help the community.

AusTrials are currently running a number of Covid-19 clinical research vaccine studies. If you are interested in learning more or volunteering, please contact AusTrials on 07 3278 5255 or follow the link below.

Eligible participants will be compensated for time and travel.

Use the links at the bottom of the page to share this study on social media or by email with friends or family who may be interested.

Respiratory Syncytial Virus (RSV) is a contagious virus that causes lower respiratory illness. For most people, RSV infection presents like a common cold and resolves quickly. However, for older adults, it can lead to more serious complications, even hospitalisation.

Here at AusTrials, we are conducting a research study to test the safety and immune response of an experimental vaccine for RSV when co-administered with an approved influenza vaccine.

You may be eligible for this study if you:

• Are over the age of 65
• Are generally healthy or have stable chronic medical conditions
• Have not had a flu vaccine in the last six months

This study is being conducted at the following locations:

• Taringa, QLD
• Wellers Hill, QLD

The study involves three clinic visits over two months. Eligible participants will receive the vaccinations free of charge and will be compensated for their time and effort.

Please contact AusTrials on 07 3278 5255 for further information or follow the link below and we will get back to you.

Use the links at the bottom of the page to share this study on social media or by email with friends or family who may be interested.

With the emergence of new variants of COVID-19 spreading in the community, there is a need to evaluate booster vaccines to overcome decreasing immunity. In addition, seasonal influenza (flu) also remains a public health concern throughout the ongoing COVID-19 pandemic.

Here at AusTrials, we are testing the Pfizer-BioNTech COVID-19 vaccine as an investigational fourth dose booster, administered alongside a flu vaccine.

The study involves three visits to our dedicated research facility. Eligible participants will be compensated for their time and effort.

You may be eligible for this study if you:

• Are between 18 and 64 years of age
• Have received three prior doses of the Pfizer-BioNTech COVID-19 vaccine, with the third dose received at least three months ago

The study is being conducted at the following location:

• Wellers Hill, QLD

Please contact AusTrials on 07 3278 5255 for further information or follow the link below and we will get back to you.

Use the links at the bottom of the page to share this study on social media or by email with friends or family who may be interested.

In eosinophilic asthma, an increase in white blood cells can cause inflammation of the airways leading to severe asthma attacks.

Here at AusTrials, we are conducting a research study to test an experimental medication for eosinophilic asthma which is given as an injection under the skin.

Treatments that are currently available often need to be taken every 1 to 2 months. It is hoped that the study drug can be taken every 6 months, so less frequent treatments are required, potentially making asthma care feel less overwhelming.

You may be eligible for this study if you:

• Are over the age of 12
• Have had eosinophilic asthma for at least two years
• Have been taking mepolizumab or benralizumab for at least 12 months, with a documented benefit from the treatment
• Require regular treatment of asthma attacks with inhaled corticosteroids and at least one other medication

The study is being conducted at the following location:

• Taringa, QLD

Eligible participants will be compensated for their time and effort.

Please contact AusTrials on 07 3278 5255 for further information or follow the link below and we will get back to you.

Use the links at the bottom of the page to share this study on social media or by email with friends or family who may be interested.

Chronic Obstructive Pulmonary Disease (COPD) is a condition in which inflammation of the lung tissue causes obstruction of the airways. This makes it difficult to breath and can cause coughing, wheezing and sputum production. The condition is often linked to smoking.

Here at AusTrials, we are conducting a research study testing an experimental medication for COPD. The study medication will be given as an injection under the skin.

You may be eligible to take part if you:

• Are between 40 and 75 years of age
• Have COPD
• Are a current or ex-smoker

This study is being conducted at the following location:

• Wellers Hill, QLD

Eligible participants will be reimbursed for travel costs to clinic visits.

Please contact AusTrials on 07 3278 5255 for further information or follow the link below and we will get back to you.

Use the links at the bottom of the page to share this study on social media or by email with friends or family who may be interested.

Diabetes can cause serious complications, including heart disease

If you have type 2 diabetes, consider joining a study to test a possible therapy for preventing heart damage caused by diabetes.

Key study entry requirements:

• Type 2 diabetes
• At least 40 years old

Note: Other criteria apply

Qualified study participants will receive:

• Potential access to an investigational study drug at no cost. Note: Some participants will receive a placebo (dummy pill)
• Study-related support and monitoring by a health care team
• Education about diabetic complications, including heart damage
• Reimbursement for time and travel

The study is being conducted at the following location:

• Taringa, QLD

Contact AusTrials on 07 3278 5255 for further information, visit https://clinicaltrials.gov/ct2/show/NCT04083339 or fill out the form below and we will get back to you.

Use the links at the bottom of the page to share this study on social media or by email with friends or family who may be interested.

AusTrials are currently studying Papaw ointment as a potential treatment for skin conditions such as mild eczema and/or rash, cracked or dry skin on heels, insect bites and sunburn.

The study involves two visits to our dedicated research facility over a period of either 10 or 21 days. Eligible participants will be compensated for their time and effort.

You may be eligible to participate if you are 18 to 50 years of age and currently experiencing mild eczema and/or rash, cracked or dry skin on heels, insect bites or sunburn.

This study is being conducted at the following locations:

• Taringa, QLD
• Wellers Hill, QLD

Please contact AusTrials on 07 3278 5255 for further information or follow the link below and we will get back to you.

Use the links at the bottom of the page to share this study on social media or by email with friends or family who may be interested.

Respiratory Syncytial Virus (RSV) is highly contagious and usually presents like a common cold. However, it can also cause more serious respiratory illness and can lead to complications in older adults, such as pneumonia. It can be fatal.

Here at AusTrials, we are running a clinical study testing a new vaccine which may prevent RSV infection in older adults.

The study involves visits to our dedicated research facilities, along with scheduled telephone contacts.

You may be eligible to participate if you are:

• 60 years of age or older

Eligible participants will receive vaccinations free of charge and will be paid for their time and effort.

The study is being conducted at the following locations:

• Taringa, QLD
• Wellers Hill, QLD
• Morayfield, QLD

Please contact AusTrials on 07 3278 5255 for further information or follow the link below and we will get back to you.

Use the links at the bottom of the page to share this study on social media or by email with friends or family who may be interested.

Low libido can cause significant distress and can have a negative impact on relationships. The official term is Hypoactive Sexual Desire Disorder (HSDD), and symptoms can include having a lack of interest or desire for sexual activity and reduced or absent sexual thoughts.

Here at AusTrials we are conducting a research study to test an investigational treatment for women who are affected with low libido or believe they may have Hypoactive Sexual Desire Disorder.

The study involves up to five visits to the clinic and five scheduled telephone calls. Eligible participants will be compensated $100 per clinic visit for their time and effort.

You may be eligible to participate if you are:

• female
• aged between 21 and 50 years (and are premenopausal)
• in a stable relationship

This study is being conducted at the following locations:

• Taringa
• Wellers Hill (Tarragindi)

Please contact AusTrials on 07 3278 5255 for further information or fill out the form below and we will get back to you. Use the links at the bottom of the page to share this study on social media or by email with friends or family who may be interested.

Meningococcal Disease is rare, but can be sudden, potentially cause devastating lifelong impairments and can be fatal. Teens and young adults are at higher risk of infection.

Here at AusTrials, we are conducting a research study testing a potential new vaccine that may act as a booster for people who have already been vaccinated against Meningococcal Disease.

The study will involve four visits to our dedicated research facility in Taringa or Wellers Hill and up to five follow-up phone calls.

You may be eligible to take part if:

• You are healthy and between 15 and 25 years old
• You have previously been vaccinated against Meningococcal Disease

This study is being conducted at the following locations:

• Taringa, QLD
• Wellers Hill, QLD

Eligible participants will be compensated for their time and effort.

Please contact AusTrials on 07 3278 5255 for further information or follow the link below and we will get back to you.

Use the links at the bottom of the page to share this study on social media or by email with friends or family who may be interested.

Potential participants under 18 years old must be accompanied by a parent or a legal guardian at all study visits, who must consent to study participation.

Symptoms of flu-like illness can include fever, headache, chills, muscle or joint pain, fatigue, cough, sore throat, and nasal congestion. These symptoms can be caused by an excess release of inflammatory chemicals from cells of the immune system.

Here at AusTrials, we are running a clinical study testing a potential treatment for flu-like illness. The product being tested is already in use to treat allergic eye conditions by reducing the release of inflammatory chemicals.

The study involves 3 visits to our dedicated research facility and 1 follow-up phone call. Eligible participants will be compensated for their time and effort.

You may be eligible to participate if you are:

• 18 to 64 years of age
• Currently experiencing a fever of at least 38 ºC
• Currently experiencing a headache, chills, muscle/joint pain, or fatigue along with a cough, sore throat, or nasal congestion

This study is being conducted at the following location:

• Wellers Hill, QLD

Please contact AusTrials on 07 3278 5255 for further information or follow the link below and we will get in touch.

Use the links at the bottom of the page to share this study on social media or by email with friends or family who may be interested.

Anaemia is a decrease in red blood cells which can cause tiredness, weakness, shortness of breath and fatigue. There are many causes of anaemia in those over 65 years of age, including nutritional deficiencies and chronic inflammatory diseases. In some cases, an underlying reason cannot be found.

Here at AusTrials, we are running a clinical study testing a potential treatment for Anaemia of Ageing.

The study involves up to 16 visits to our dedicated research facility. Eligible participants will be compensated for their time and effort.

You may be eligible to participate if:

• You are 65 years of age or older
• You have symptoms of anaemia (tiredness, weakness, shortness of breath and/or fatigue)

This study is being conducted at the following locations:

• Taringa, QLD
• Wellers Hill, QLD

Please contact AusTrials on 07 3278 5255 for further information or follow the link below and we will get back to you.

Use the links at the bottom of the page to share this study on social media or by email with friends or family who may be interested.

Vaccination is the main method for preventing the flu and its complications. In older adults, the body’s natural defence against infection can be weakened. This may make the currently available vaccines less effective.

Here at AusTrials, we are running a clinical study testing a potential new flu vaccine that has been designed to provide a stronger immune response.

The study involves up to three visits to our dedicated research facility and two scheduled telephone calls. Eligible participants will be compensated for their time and effort.

You may be eligible to participate if you are:

• 50 years of age or older

This study is being conducted at the following locations:

• Taringa
• Wellers Hill

Please contact AusTrials on 07 3278 5255 for further information or fill out the form below and we will get back to you. Use the links at the bottom of the page to share this study on social media or by email with friends or family who may be interested.

Osteoporosis is a ‘silent’ condition in which a loss of bone density increases the risk of serious fractures.

Here at AusTrials we are conducting an observational study in women over the age of 50 who have experienced a fracture due to their osteoporosis in the last 12 months, in comparison to women over the age of 50 who have not recently experienced a fracture.

The study aims to investigate the effects of osteoporotic fractures on productivity (in terms of decreased paid or unpaid work) and physical functioning during activities of daily living.

This study consists of a review of medical history and completion of a survey. Eligible participants will be compensated $50 for their time and effort.

The study is being conducted at three AusTrials clinics across Brisbane:

• Taringa
• Victoria Point
• Wellers Hill (Tarragindi)

Please contact AusTrials on 07 3278 5255 for further information or fill out the form below and we will get back to you. Use the links at the bottom of the page to share this study on social media or by email with friends or family who may be interested.

Have you been diagnosed with kidney disease due to your diabetes and are currently on a common blood pressure medication? If so, you may able to take part in a clinical study of a new treatment for people with type 2 diabetes that AusTrials is conducting at the Westside Private Hospital in Taringa.

You may be able to take part in the study if you are:

• 18 Years and older, of either sex
• Have type 2 diabetes
• Have been diagnosed with kidney disease (by finding protein in your urine)
• On one of two commonly used medications for your blood pressure

Medications ending in  –pril  eg. Enalapril, Captopril, etc

Medications ending in -sartan eg. Irbesartan, Candesartan etc

The study is being conducted at this location:

• Taringa, QLD

Qualified participants will receive:

• Study medications and visits at no cost
• Diabetes education – fully funded
• Compensation for time and travel involved in the study.

Please contact AusTrials on 07 3278 5255 for further information, or fill out the form below and we will get back to you.

Use the links at the bottom of the page to share this trial on social media or by email with friends or family who may be interested.